Verseau Therapeutics

Verseau Therapeutics

Verseau Therapeutics

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators (MCMs), to benefit patients with cancer, immune and inflammatory diseases.
Raised
$50M
Follow us
Alexa global traffic share
Twitter followers
22 Oct 2019

China’s 3SBio, Highlight Capital, Yonghua back $50m Verseau Therapeutics round

DealStreetAsia
+1